Anthony Rothschild is a Psychiatry physician affiliated with UMass Memorial Health Care. OpenAlex indexes 271 publications with 8,732 citations (h-index 49); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
55 Lake Ave N
Worcester, MA 016550002
Telephone
508-856-5928Provider last certified this registry record 3 Dec 2020.
Clinical trials
- Sustaining Remission of Psychotic Depression
Sponsor: Weill Medical College of Cornell University
- Treatment-Resistant Depression Registry
Sponsor: Cyberonics, Inc.
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
6 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Axsome Therapeutics, Inc.Program year20251 payment
- ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)Program year20251 payment
- Boehringer Ingelheim Pharmaceuticals, Inc.Program year20241 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
100%Benzodiazepine20.9%Lorazepam100%Part D<11 patientsSSRI20.9%Trazodone Hcl68%Sertraline Hcl32%Part D<11 patients+ 5 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
2 NIH research awards on record, funded 1991–2015 per NIH RePORTER. The latest:
- 2/4-Sustaining Remission of Psychotic Depression
Univ of Massachusetts Med Sch Worcester
FY2015$248,226U01MH062624 - 2/4-Sustaining Remission of Psychotic Depression
Univ of Massachusetts Med Sch Worcester
FY2014$305,960U01MH062624 - 2/4-Sustaining Remission of Psychotic Depression
Univ of Massachusetts Med Sch Worcester
FY2013$293,723U01MH062624
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
Gerard Aurigemma, MD
UMass Memorial Health Care
Richard Irwin, MD
UMass Memorial Health Care
Craig Lilly, MD
UMass Memorial Health Care
David Keefe, MD
UMass Memorial Health Care
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”